Back to Agenda
Digital Technologies and Their Promise of Increased Technical Success, Reduced Timelines and Broader Generalizability of Findings
Session Chair(s)
Jennifer Goldsack, MA, MBA, MS
Chief Executive Officer
Digital Medicine Society (DiMe), United States
In this session we will cut through the noise and use case examples to describe real opportunities to pursue the promise of clinical trials with increased likelihood of technical success, reduced timelines & broader generalizability of findings.
Learning Objective : Identify opportunities for higher quality, lower burden, more informative assessments using digital technologies Recognize how digital technologies can support high quality, accessible, & efficient clinical trials through measurement, & beyond Describe use cases demonstrating the success of digital technologies in clinical trials that can be readily applied by participants following this session
Speaker(s)
Selecting Digital Solutions as a Pharmaceutical Company
Quentin Le Masne, PhD
Merck Group, Switzerland
Head of Product Development, Connected Health & Devices
Real World Data & Mobility Assessment in Clinical Trials
Alexis Mathieu, MSc
FeetMe, France
CEO
How Smart Packages Enable Digital Adherence Monitoring for Successful Clinical Trials
Bernard Vrijens, PhD
AARDEX Group, Belgium
CEO & Scientific Lead
Challenges & Opportunities for Digital Health in the Context of Clinical Studies
Jorge Cancela, PhD, MBA
Roche, Switzerland
Digital Health Leader
Have an account?